Trial Profile
A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol (GWP42003-P)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs Cannabidiol (Primary) ; Clobazam
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Jazz Pharmaceuticals Inc
- 11 Jul 2020 Results published in the Journal of Clinical Pharmacology
- 17 Mar 2017 Status changed from active, no longer recruiting to completed.
- 14 Jul 2016 Status changed from recruiting to active, no longer recruiting.